SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001171843-23-005430
Filing Date
2023-08-25
Accepted
2023-08-25 06:00:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 f424b3_082423.htm 424B3 743920
2 GRAPHIC logo.jpg GRAPHIC 11053
  Complete submission text file 0001171843-23-005430.txt   760241
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-267328 | Film No.: 231203724
SIC: 2834 Pharmaceutical Preparations